Colgate-Palmolive vs Coca-Cola Europacific Partners
Colgate-Palmolive vs Coca-Cola Europacific Partners: this page compares their business models, financial performance, and market context in a neutral, accessible way. You will see how each company approaches growth, operational structure, and competitive environments, without asserting any claims or forecasts. Educational content, not financial advice.
Colgate-Palmolive vs Coca-Cola Europacific Partners: this page compares their business models, financial performance, and market context in a neutral, accessible way. You will see how each company app...
Why It's Moving
Colgate-Palmolive Faces Analyst Skepticism Despite Earnings Beat and Dividend Raise
- Q4 earnings beat analyst estimates ($0.95 vs. $0.91 expected) with revenue growth of 5.8% year-over-year, demonstrating underlying operational strength in core categories
- Quarterly dividend raised to $0.53 (annualized $2.12 with ~2.4% yield), reflecting management confidence, though insider selling of 184,683 shares worth roughly $17.49 million last quarter signals caution from company insiders
- A $794 million after-tax goodwill and intangible impairment tied to the skin health business overshadows results; 2026 guidance projects only 2-6% net sales growth and 1-4% organic growth, below recent performance trajectory
CCEP Stock Trading Near $101 After Strong FY25 Results and Aggressive Buyback Push
- FY25 operating profit surged 31% to €2.79B with comparable diluted EPS up 6.2% to €4.11, demonstrating earnings strength and prompting the company to maintain its €2.04 dividend while guiding for 3-4% revenue growth in 2026
- Active March buyback activity saw CCEP repurchase approximately 589,923 shares across US and London venues between March 2-9 at prices ranging from $101.94 to $110.67 on US exchanges, with all shares designated for cancellation as part of its €1 billion program
- Seven of ten research analysts rate the stock as a Buy with an average price target of $107.71, though shares opened at $101.13 on March 13 trading within a 52-week range of $81-$110.90, with institutional investors holding approximately 31.35% of shares outstanding
Colgate-Palmolive Faces Analyst Skepticism Despite Earnings Beat and Dividend Raise
- Q4 earnings beat analyst estimates ($0.95 vs. $0.91 expected) with revenue growth of 5.8% year-over-year, demonstrating underlying operational strength in core categories
- Quarterly dividend raised to $0.53 (annualized $2.12 with ~2.4% yield), reflecting management confidence, though insider selling of 184,683 shares worth roughly $17.49 million last quarter signals caution from company insiders
- A $794 million after-tax goodwill and intangible impairment tied to the skin health business overshadows results; 2026 guidance projects only 2-6% net sales growth and 1-4% organic growth, below recent performance trajectory
CCEP Stock Trading Near $101 After Strong FY25 Results and Aggressive Buyback Push
- FY25 operating profit surged 31% to €2.79B with comparable diluted EPS up 6.2% to €4.11, demonstrating earnings strength and prompting the company to maintain its €2.04 dividend while guiding for 3-4% revenue growth in 2026
- Active March buyback activity saw CCEP repurchase approximately 589,923 shares across US and London venues between March 2-9 at prices ranging from $101.94 to $110.67 on US exchanges, with all shares designated for cancellation as part of its €1 billion program
- Seven of ten research analysts rate the stock as a Buy with an average price target of $107.71, though shares opened at $101.13 on March 13 trading within a 52-week range of $81-$110.90, with institutional investors holding approximately 31.35% of shares outstanding
Investment Analysis
Pros
- Colgate-Palmolive achieved organic sales growth of 2.4% in Q2 2025, demonstrating resilience despite inflation and foreign exchange headwinds.
- The company maintains a strong global market position in household and personal care products, supported by high gross profit margins of over 60%.
- Colgate-Palmolive offers a stable dividend yield of around 2.7%, appealing to income-focused investors seeking consistent returns.
Considerations
- The stock trades at a premium valuation, with a P/E ratio above sector average, which may limit upside for new investors.
- Recent analyst price targets have been lowered, reflecting concerns about future growth and limited share price appreciation over the past year.
- Colgate-Palmolive faces ongoing exposure to raw material cost pressures and currency volatility, which could impact profitability.
Pros
- Coca-Cola Europacific Partners benefits from strong brand recognition and a dominant position in the European and Pacific beverage markets.
- The company has demonstrated consistent revenue growth, supported by a diversified product portfolio and strategic distribution networks.
- It maintains healthy operating margins and a solid return on equity, reflecting efficient capital allocation and operational discipline.
Considerations
- The business is exposed to regulatory risks and changing consumer preferences, particularly around sugar content and health concerns.
- Coca-Cola Europacific Partners faces competitive pressures from both global and local beverage brands, which could constrain pricing power.
- The company's performance is sensitive to macroeconomic factors, including inflation and currency fluctuations, especially in its international markets.
Related Market Insights
Beyond Beer: The Premium Consumer Playbook
Discover how premium consumer brands like PG, KO, PEP drive profits despite volume declines. Explore resilient growth in emerging markets & invest via Nemo's Neme.
Aimee Silverwood | Financial Analyst
July 28, 2025
Related Market Insights
Beyond Beer: The Premium Consumer Playbook
Discover how premium consumer brands like PG, KO, PEP drive profits despite volume declines. Explore resilient growth in emerging markets & invest via Nemo's Neme.
Aimee Silverwood | Financial Analyst
July 28, 2025
Colgate-Palmolive (CL) Next Earnings Date
I cannot provide the requested information because the search results provided are for Continental AG (CTTAY), a European automotive and tire manufacturer, not for CL Stock. The query appears to reference a different company entirely. To accurately answer when the next earnings date is for CL Stock, I would need search results specific to that ticker symbol. If you're looking for Continental AG's earnings dates, I can provide that information instead.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
Coca-Cola Europacific Partners (CCEP) is estimated to announce earnings between March 24 and March 30, 2026, based on historical release patterns. This earnings report will cover the first quarter of 2026. The company typically releases quarterly results in the morning before market open or after the close of trading. Investors should monitor the company's investor relations website for the precise announcement date and time.
Colgate-Palmolive (CL) Next Earnings Date
I cannot provide the requested information because the search results provided are for Continental AG (CTTAY), a European automotive and tire manufacturer, not for CL Stock. The query appears to reference a different company entirely. To accurately answer when the next earnings date is for CL Stock, I would need search results specific to that ticker symbol. If you're looking for Continental AG's earnings dates, I can provide that information instead.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
Coca-Cola Europacific Partners (CCEP) is estimated to announce earnings between March 24 and March 30, 2026, based on historical release patterns. This earnings report will cover the first quarter of 2026. The company typically releases quarterly results in the morning before market open or after the close of trading. Investors should monitor the company's investor relations website for the precise announcement date and time.
Which Baskets Do They Appear In?
Beyond Beer: The Premium Consumer Playbook
Heineken's recent earnings show that strong brand power and growth in emerging markets can drive profits even when sales volumes dip in key regions. This suggests an investment opportunity in other global consumer companies using a similar strategy to navigate economic challenges.
Published: July 28, 2025
Explore BasketWhich Baskets Do They Appear In?
Beyond Beer: The Premium Consumer Playbook
Heineken's recent earnings show that strong brand power and growth in emerging markets can drive profits even when sales volumes dip in key regions. This suggests an investment opportunity in other global consumer companies using a similar strategy to navigate economic challenges.
Published: July 28, 2025
Explore BasketBuy CL or CCEP in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Colgate-Palmolive vs Kroger
A neutral Colgate-Palmolive vs Kroger stock comparison outlining business models, financial performance and market context to guide research decisions.
Colgate-Palmolive vs Diageo
A neutral, factual comparison of Colgate-Palmolive Co. and Diageo plc, examining business models, recent financial performance, and market context without advocacy.
Colgate-Palmolive vs Ambev
Colgate-Palmolive vs Ambev compares business models, key financials, and market context to help readers research each company with neutral, accessible language for investors.